Genetic markers were selected to represent the pathways most frequently altered in colon cancer, such as the WNT-pathway (surrogate marker osteopontin), mutations in the oncogenes KRAS and BRAF, and the DNA microsatellite status. The gene discussed is SPP1; the disease is malignant colon neoplasm.